arrow
W

Wouter V. Vogel

Error
H指数:45
被引数:6,196

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer

PROQURE-I:一项在根治性治疗N1期前列腺癌中,将[177Lu]Lu-PSMA-617与EBRT和ADT联合应用的I期研究

2026-05-270
OAAI
Smart scanning for two: [18F]FDG dose optimization for pregnant patients using LAFOV PET/CT technology

双人智能扫描:使用LAFOV PET/CT技术对孕妇进行[18F]FDG剂量优化

2026-03-170
OAAI
SPECT/CT-based sentinel node procedure to guide unilateral elective nodal irradiation in patients with head and neck cancer: technical feasibility and sentinel node mapping outcomes

SPECT/CT引导下的前哨淋巴结活检术用于头颈癌患者单侧选择性淋巴结照射的指导:技术可行性与前哨淋巴结显像结果

2025-11-010
PRE
[18F]FDG-PET/CT’s change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial

[18F]FDG-PET/CT的总病灶糖酵解变化能够准确识别在接受新辅助免疫疗法后根治性手术前的早期反应;MATISSE试验

2025-10-280
OA
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial

新辅助伊匹木单抗和纳武利尤单抗在可切除皮肤鳞状细胞癌中的应用:一项随机Ⅱ期临床试验

2025-10-080
OAAI
Optimizing diagnostic pathways through digital multidisciplinary team management of patients with cancer of unknown primary: a retrospective analysis

通过数字多学科团队管理对未知原发灶癌症患者进行诊断路径优化:一项回顾性分析

2025-10-010
PRE
[195mPt]Cisplatin for lung cancer imaging: a pilot study

[195mPt]顺铂用于肺癌成像:一项初步研究

2025-07-160
OA
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration- resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study

先前接受卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的177前列腺特异性膜抗原活性和预后决定因素: PACAP研究

2024-10-010
OA
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis

使用 [18F]FDG PET/CT识别原发性未知癌 (CUP) 患者的原发性肿瘤: 系统回顾和个体患者数据荟萃分析

2024-08-140
OAAI
Away from definition and back to the clinic - As response to Kumar et al, 'Evidence is not sufficient to declare the tubal gland conglomerates as salivary'

远离定义,回到诊所-作为对Kumar等人的回应,“证据不足以宣布输卵管腺团块为唾液”

2024-01-011
OAAI
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial

局部晚期非小细胞肺癌患者的18F-FDG-PET指导与全肿瘤放疗剂量递增 (PET-Boost): 一项随机临床试验的结果

2023-04-0128
OAAI